OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting SARS-CoV-2 nonstructural protein 3: Function, structure, inhibition, and perspective in drug discovery
Xin Li, Yongcheng Song
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103832-103832
Open Access | Times Cited: 11
Xin Li, Yongcheng Song
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103832-103832
Open Access | Times Cited: 11
Showing 11 citing articles:
Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity
Jenny Desantis, Alessandro Bazzacco, Michela Eleuteri, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116202-116202
Open Access | Times Cited: 10
Jenny Desantis, Alessandro Bazzacco, Michela Eleuteri, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116202-116202
Open Access | Times Cited: 10
Discovery of 2-Amide-3-methylester Thiophenes that Target SARS-CoV-2 Mac1 and Repress Coronavirus Replication, Validating Mac1 as an Antiviral Target
Sarah Wazir, Tomi A. O. Parviainen, Jessica J. Pfannenstiel, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6519-6536
Closed Access | Times Cited: 9
Sarah Wazir, Tomi A. O. Parviainen, Jessica J. Pfannenstiel, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6519-6536
Closed Access | Times Cited: 9
Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19
Yongzhi Lu, Qi Yang, Ting Ran, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Yongzhi Lu, Qi Yang, Ting Ran, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Novel Papain-Like Protease Inhibitors for Treating Viral Infections, in particular, Coronavirus Infections
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 8, pp. 1186-1187
Closed Access | Times Cited: 3
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 8, pp. 1186-1187
Closed Access | Times Cited: 3
Anticoronavirus activity of rhizome of Dryopteris crassirhizoma via multistage targeting of virus entry and viral proteases, Mpro and PLpro
Mobashira Habib, Young-Hee Jin, Yeon‐Hwa Kim, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118490-118490
Open Access | Times Cited: 2
Mobashira Habib, Young-Hee Jin, Yeon‐Hwa Kim, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118490-118490
Open Access | Times Cited: 2
Xiaoer niuhuang qingxin powder alleviates influenza a virus infection by inhibiting the activation of the TLR4/MyD88/NF-κB signaling pathway
Lanying Ma, Tong Wang, Meiyi Liu, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 118000-118000
Closed Access | Times Cited: 1
Lanying Ma, Tong Wang, Meiyi Liu, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 118000-118000
Closed Access | Times Cited: 1
Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19
Yongzhi Lu, Qi Yang, Ting Ran, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Yongzhi Lu, Qi Yang, Ting Ran, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Lessons learnt from broad-spectrum coronavirus antiviral drug discovery
Andrew A. Bolinger, Jun Li, Xuping Xie, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1023-1041
Closed Access | Times Cited: 1
Andrew A. Bolinger, Jun Li, Xuping Xie, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1023-1041
Closed Access | Times Cited: 1
Design, synthesis, and evaluation of pyranochromene derivatives as membrane targeting antibacterials against Gram-positive bacteria
Yinhu Wang, Guoqing Miao, Shuo Wang, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 113, pp. 129949-129949
Closed Access | Times Cited: 1
Yinhu Wang, Guoqing Miao, Shuo Wang, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 113, pp. 129949-129949
Closed Access | Times Cited: 1
Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition
Xin Li, Yongcheng Song
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 18642-18655
Closed Access | Times Cited: 1
Xin Li, Yongcheng Song
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 18642-18655
Closed Access | Times Cited: 1
Diosmetin-7-O-β-D-glucopyranoside from Pogostemonis Herba alleviated SARS-CoV-2-induced pneumonia by reshaping macrophage polarization and limiting viral replication
Yunlu Xu, Xuejian Li, Wei Cai, et al.
Journal of Ethnopharmacology (2024) Vol. 336, pp. 118704-118704
Closed Access
Yunlu Xu, Xuejian Li, Wei Cai, et al.
Journal of Ethnopharmacology (2024) Vol. 336, pp. 118704-118704
Closed Access
